Adjuvant radiotherapy did not increase the risk of coronary heart disease in patients with non-metastatic breast cancer

References

• Cancer Statistics Annual Report: Taiwan Cancer Registry. Available from. cited 2021 Sep 29. https://www.hpa.gov.tw/Pages/Detail.aspx?nodeid=269&pid=13498
   Google Scholar
• Afifi AM, Saad AM, Al-Husseini MJ, et al. Causes of death after breast cancer diagnosis: a US population-bases analysis. Cancer. 2020;126(7):1559–1567.
   PubMed Web of Science ®Google Scholar
• Darby S, McGale P, Correa C, et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 2011;378:1707–1716.
   PubMed Web of Science ®Google Scholar
• Kaufmann M, Morrow M, Von Minckwitz G, et al. Locoregional treatment of primary breast cancer: consensus recommendations from an international expert panel. Cancer. 2010;116(5):1184–1191.
   PubMed Web of Science ®Google Scholar
• McGale P, Darby SC, Hall P, et al. Incidence of heart disease in 35,000 women treated with radiotherapy for breast cancer in Denmark and Sweden. Radiother Oncol. 2011;100(2):167–175.
   PubMed Web of Science ®Google Scholar
• Ministry of health and welfare website of Taiwan. cited 2021 Sep 21]. https://www.mohw.gov.tw/cp-16-48057-1.html
   Google Scholar
• Mehta LS, Watson KE, Barac A, et al. Cardiovascular disease and breast cancer: where these entities intersect: a scientific statement from the American Heart Association. Circulation. 2018;137(8):e30–e66.
   PubMed Web of Science ®Google Scholar
• Harris EER, Correa C, Hwang WT, et al. Late cardiac mortality and morbidity in early-stage breast cancer patients after breast-conservation treatment. J Clin Oncol. 2006;24(25):4100–4106.
   PubMed Web of Science ®Google Scholar
• Boekel NB, Schaapveld M, Gietema JA, et al. Cardiovascular disease risk in a large, population-based cohort of breast cancer survivors. Int J Radiat Oncol Biol Phys. 2016;94(5):1061–1072.
   PubMed Web of Science ®Google Scholar
• Taylor C, Correa C, Duane FK, et al. Estimating the risks of breast cancer radiotherapy: evidence from modern radiation doses to the lungs and heart and from previous randomized trials. J Clin Oncol. 2017;35(15):1641–1649.
   PubMed Web of Science ®Google Scholar
• Hooning MJ, Botma A, Aleman BMP, et al. Long-term risk of cardiovascular disease in 10-year survivors of breast cancer. J Natl Cancer Inst. 2007;999(5):365–375.
   Google Scholar
• Nixon AJ, Manola J, Gelman R, et al. No long-term increase in cardiac-related mortality after breast-conserving surgery and radiation therapy using modern techniques. J Clin Oncol. 1998;16(4):1374–1379.
   PubMed Web of Science ®Google Scholar
• Hojris I, Overgaard M, Christensen JJ, et al. Morbidity and mortality of ischaemic heart disease in high risk breast cancer patients after adjuvant postmastectomy systemic treatment with or without radiotherapy: analysis of DBCG 82b and 82c randomised trials. Lancet. 1999;354(9188):1425–1430.
   PubMed Web of Science ®Google Scholar
• Vallis K, Pintilie M, Chong N, et al. Assessment of coronary heart disease morbidity and mortality after radiation therapy for early breast cancer. J Clin Oncol. 2002;20(4):1036–1042.
   PubMed Web of Science ®Google Scholar
• Rutqvist LE, Liedberg A, Hammar N, et al. Myocardial infarction among women with early stage breast cancer treated with conservative surgery and breast irradiation. Int J Radiat Oncol Biol Phys. 1998;40(2):359–363.
   PubMed Web of Science ®Google Scholar
• Khosrow-Khavar F, Filion KB, AI-Qurashi S, et al. Cardiotoxicity of aromatase inhibitors and tamoxifen in postmenopausal women with breast cancer: a systematic review and meta-analysis of randomized controlled trials. Ann Oncol. 2016;28(3):487–496.
   Web of Science ®Google Scholar
• Levis BE, Binkley PF, Shapiro CL. Cardiotoxic effects of anthracycline-based therapy: what is the evidence and what are the potential harms? Lancet Oncol. 2017;18(8):e445–e456.
   PubMed Web of Science ®Google Scholar
• Darby SC, Ewterz M, McGale P, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 2013;368(11):987–998.
   PubMed Web of Science ®Google Scholar
• Carlson LE, Watt GP, Tonorezos ES, et al. Coronary artery disease in young women after radiation therapy for breast cancer: the WECARE Study. J Am Coll Cardiol CardioOnc. 2021;3. 381–392.
   Google Scholar
• Armenian SH, Lacchetti C, Barac A, et al. Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2017;35(8):893–911.
   PubMed Web of Science ®Google Scholar
• Matthews A, Stanway S, Farmer RE, et al. Long term adjuvant endocrine therapy and risk of cardiovascular disease in female breast cancer survivors: systematic review. BMJ. 2018;363:k3845.
   PubMedGoogle Scholar
• Lai SW, Lin CL, Liao KF. Association between tamoxifen use and acute myocardial infarction in women with breast cancer. Medicine (Baltimore). 2019;98(3):e13925.
   PubMed Web of Science ®Google Scholar
• Yang TL, Tc W, Huang CC, et al. Association of tamoxifen use and reduced cardiovascular events among Asian females with breast cancer. Circ J. 2014;78(1):135–140.
   PubMed Web of Science ®Google Scholar
• Chou YH, Huang JY, Kornelius E, et al. Major adverse cardiovascular events after treatment in early-stage breast cancer patients receiving hormone therapy. Sci Rep. 2020;10(1):1408.
   PubMed Web of Science ®Google Scholar
• Zhao L, Zhang B. Doxorubicin induces cardiotoxicity through upregulation of death receptors mediated apoptosis in cardiomyocytes. Sci Rep. 2017;7:44375.
   PubMed Web of Science ®Google Scholar
• Haussmann J, Corradini S, Nestle-Kraemling C, et al. Recent advances in radiotherapy of breast cancer. Radiat Oncol. 2020;15(1):71.
   PubMed Web of Science ®Google Scholar
• Shah C, Badiyan S, Berry S, et al. Cardiac dose sparing and avoidance techniques in breast cancer radiotherapy. Radiother Oncol. 2014;112(1):9–16.
   PubMed Web of Science ®Google Scholar
• Gocer GPS, Ozer EE. Effect of radiotherapy on coronary arteries and heart in breast-conserving surgery: a dosimetric analysis. Radiol Oncol. 2020;54(1):128–134.
   PubMed Web of Science ®Google Scholar
• Haque W, Verma V, Haque A, et al. Trends in cardiac mortality in women with ductal carcinoma in situ. Breast Cancer Res Treat. 2017;161(2):345–351.
   PubMed Web of Science ®Google Scholar
• Valachis A, Nilsson C. Cardiac risk in the treatment of breast cancer: assessment and management. Breast Cancer. 2015;7:21–35.
   PubMed Web of Science ®Google Scholar
• McGale P, Cutter D, Darby SC, et al. Can observational data replace randomised trials? J Clin Oncol. 2016;34(27):3355–3356.
   PubMed Web of Science ®Google Scholar
• Liau CS, Tseng YZ, Lee TK. Prevalence of cardiovascular diseases in elderly Chinese people in Taiwan. Int J Cardiol. 1998;67(2):177–181.
   PubMed Web of Science ®Google Scholar